Skip to main content

Industry News

Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.

Ivanhoé Cambridge and Lendlease Plan Boston Life Sciences Facility

Published 9/13/2021

Ivanhoé Cambridge and Lendlease will break ground in summer of 2022 on a 320,000-sf life sciences facility in Boston. Designed by SGA, the nine-story building will provide state-of-the-art labs, offices, and collaboration spaces for biomedical and pharmaceutical tenants. Offering BSL-1 and BSL-2 research environments, the amenity-rich structure will include a multipurpose ground floor, a parking garage, and numerous outdoor areas.

Read More

Precision NanoSystems Constructs Headquarters and Biomanufacturing Center

Published 8/27/2021

Precision NanoSystems is constructing its global headquarters in Vancouver, British Columbia. Located in the four-story Evolution Block building, the 75,000-sf leased facility will feature a GMP biomanufacturing center for the production of genetic medicines and RNA-based therapeutics. The federal government has contributed CAD$25.1 million in funding towards the project's construction to increase the nation's domestic supply of COVID-19 vaccines and prepare for future pandemics.

Read More

Washington State University Dedicates Animal Disease Diagnostic Laboratory

Published 5/24/2021

Washington State University dedicated the $61.9 million Washington Animal Disease Diagnostic Laboratory in May of 2021. Designed by Perkins&Will, the 61,000-sf facility represents an expansion of the Paul G. Allen Center for Global Animal Health in Pullman. Enabling the detection and diagnosis of human and animal diseases including SARS-CoV-2, avian influenza, BSE, and West Nile virus, the three-story building houses instructional venues, collaboration spaces, a high-bay necropsy suite, and specialized labs for testing, research, and development.

Read More

Vibalogics Creates Virotherapy Manufacturing Facility

Published 3/1/2021

Vibalogics is creating a 110,000-sf facility for the production of oncolytic viruses, viral vector vaccines, and viral vector gene therapy products in Boxborough, Mass. Supporting late-phase clinical and commercial manufacturing operations, the highly flexible structure will include 2,000-liter bioreactors, multiple cGMP production suites, offices, warehouse space, and labs for research, development, and quality control. The $150 million project involves the renovation of an existing R&D building previously occupied by Cisco Systems.

Read More